Radioembolization plus chemotherapy as first-line treatment of locally-advanced intrahepatic cholangiocarcinoma. The multi-center single-arm phase 2 MISPHEC study (14) Radiology,

RSV is an infrequent cause of ILI during periods of influenza virus circulation but can cause severe complications in hospitalized adults. Risk factors for RSV detection in adults hospitalized with ILI include cancer and immunosuppressive treatment. Specific immunization and antiviral therapy might benefit patients at risk.

Selective internal radiation therapy combined with concomitant chemotherapy seems a promising strategy as first-line treatment for unresectable intrahepatic cholangiocarcinoma.

Purpose: Radioembolization (RE) is a promising treatment option for biliary tract cancers (BTC). We report here the largest series to date using this treatment modality. Methods: We retrospectively studied data from 64 patients treated outside prospective clinical trial at our institution. We studied baseline characteristics as potential prognostic factors. We studied dose delivered to the tumor as predictive factors of outcomes in patients not receiving concomitant chemotherapy. Results: The Progression-Free Survival and Overall Survival (OS) survival were 7.6 months [95% Confidence Interval (

Disclosure of fundingLuc Beuzit received a grant from Rennes University of Medicine for this work ("Prix jeune chercheur") Short titleInter-software variability of DCE-MRI Conclusion. Significant errors were found in the calculated DCE-MR imaging pharmacokinetic parameters for the perfusion analysis SPs, resulting in poor inter-software reproducibility.